News & Updates

First-line treatment with TST001 (osemitamab) in combination with capecitabine and oxaliplatin (CAPOX) is safe and well tolerated in patients with advanced gastric/gastroesophageal junction (G/GEJ) cancer, according to a study presented at ESMO 2023.

Patients with suspected gastroesophageal reflux disease (GERD) may find it difficult to follow a time-restricted eating, reports a study. Additionally, there is weak evidence to suggest that intermittent fasting helps ease acid exposure.

Patients with nonalcoholic fatty liver disease (NAFLD) tend to have higher rates of irritable bowel syndrome (IBS) symptoms, depression, and anxiety, suggests a study.

Consumption of sugar-sweetened beverages appears to raise the risk of colorectal cancer (CRC), independent of CRC mortality, results of a meta-analysis have shown.